Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Paul Thornton
Mindray Medical International Ltd.MRPAST TOP PICKNov 13, 2009
(A Top Pick Aug 8/08. Down 18%.) Chinese company that makes imaging equipment that got FDA approval about 18 months ago. Earnings growth has tapered off. Now trading in a very flat consolidation and technically it looks like it is going to go higher.
$30.97
Stock price when the opinion was issued
$5.36
As of Nov 12, 2020. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
Manufactures imaging equipment. The selloff on Thursday was too large for the breakout so if the stock undercuts $36 you want to get out. Volatile and a bit erratic. Very good earnings growth and they got FDA approval last year so there is a lot of room for growth.
Paul ThorntonOwned
biotechnologypharmaceutical
BUY
Pretty diversified but really a play on medical devices and medical testing in China. Layer on the demographics and the need for continued health-care and support for that from the Chinese government. Stocks have been really beaten down but the businesses are still growing. Likes this one for the dynamics.
biotechnologypharmaceutical
